Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to bridge racial gaps in end-of-life care

NCT ID NCT04915079

Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called PRISM, which teaches skills like stress management and goal setting, to see if it helps racial minority patients with serious illnesses feel more resilient and communicate better with their healthcare providers. The study enrolled 28 seriously ill adults, such as those with advanced cancer or heart failure. The goal was to see if the program is feasible and acceptable, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Promoting Resilience in Stress Management (PRISM) behavioral intervention
What this could lead to
If successful, this could point toward a way to help seriously ill patients from racial minority groups feel more resilient and communicate better with their doctors.
What could go wrong
This is a very small pilot study (28 participants) testing feasibility, not effectiveness. The results may not apply to larger or different groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

28 people

The number who actually took part.

Started

Jul 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Seriously ill adults with median life expectancy of two years or less (e.g. metastatic cancer or inoperable lung cancer, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) \<35% predicted or oxygen dependence, restrictive lung disease with total lung capacity (TLC) \<50% predicted, New York Heart Association (NYHA) class III or IV heart failure, or Child's class C cirrhosis or Model for End Stage Liver Disease(MELD) \>17) * Hospitalized at either Harborview Medical Center or University of Washington Medical Center-Montlake * At least 18 years of age * English-speaking * No cognitive impairment precluding completion of surveys or participation in the PRISM sessions Exclusion Criteria: * Younger than 18 years of age * Non-English speaking * Ccgnitive impairment that would preclude completion of surveys and participation in the PRISM sessions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bias, racial are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease chronic obstructive pulmonary disease cirrhosis of liver Communication communication disorder heart failure lung carcinoma metastatic malignant neoplasm Racism restrictive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bias, racial Chronic illness Communication Discrimination, racial

Contacts and locations

Locations

  • University of Washington - Harborview Medical Center

    Seattle, Washington, 98112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.